Hsbc Holdings PLC trimmed its stake in Danaher Corporation (NYSE:DHR – Free Report) by 11.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,442,791 shares of the conglomerate’s stock after selling 184,915 shares during the period. Hsbc Holdings PLC’s holdings in Danaher were worth $330,516,000 as of its most recent filing with the SEC.
Other large investors have also recently made changes to their positions in the company. Elevated Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter valued at approximately $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth $27,000. Clal Insurance Enterprises Holdings Ltd lifted its stake in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares in the last quarter. JPL Wealth Management LLC purchased a new position in shares of Danaher during the third quarter worth $25,000. Finally, WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter worth $26,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
DHR has been the topic of several research analyst reports. Morgan Stanley cut their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Barclays lowered their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. UBS Group dropped their target price on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target on the stock. Finally, Guggenheim reduced their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.
Danaher Stock Up 0.3%
Danaher stock opened at $177.74 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock’s fifty day simple moving average is $179.62 and its 200-day simple moving average is $203.07. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $125.80 billion, a P/E ratio of 34.38, a P/E/G ratio of 2.26 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the firm earned $1.88 earnings per share. As a group, equities analysts expect that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
